These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33447638)

  • 1. Associations Between Tenofovir Diphosphate in Dried Blood Spots, Impaired Physical Function, and Fracture Risk.
    Abdo M; Coyle RP; Seifert SM; Castillo-Mancilla JR; Jankowski CM; Mawhinney S; Anderson PL; Erlandson KM
    Open Forum Infect Dis; 2021 Jan; 8(1):ofaa577. PubMed ID: 33447638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spots.
    Saderup AM; Morrow M; Libby AM; Coyle RP; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; MaWhinney S; Anderson PL; Castillo-Mancilla JR
    Pharmacotherapy; 2021 Mar; 41(3):291-298. PubMed ID: 33594735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study.
    Castillo-Mancilla JR; Edwards JA; Brijkumar J; Moosa MY; Zhao Y; Ofotokun I; Johnson BA; Lee MH; Pillay S; Pillay M; Moodley P; Kuritzkes DR; Sunpath H; Bushman LR; Ellison L; Anderson PL; Marconi VC
    J Int AIDS Soc; 2021 Dec; 24(12):e25849. PubMed ID: 34910844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy.
    Dorward J; Govender K; Moodley P; Lessells R; Samsunder N; Sookrajh Y; Fanshawe TR; Turner PJ; Butler CC; Drain PK; Hayward GN; Garrett N
    AIDS; 2024 Apr; 38(5):697-702. PubMed ID: 38126342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections.
    Castillo-Mancilla JR; Morrow M; Coyle RP; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Mawhinney S; Anderson PL
    Clin Infect Dis; 2019 Apr; 68(8):1335-1342. PubMed ID: 30137238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Tenofovir Diphosphate Levels to Predict Viremia During the Postpartum Period in Women Living With Human Immunodeficiency Virus (HIV): A Nested Case-Control Study.
    Odayar J; Orrell C; Phillips TK; Hu NC; Kabanda S; Malaba TR; Allerton J; Wiesner L; Hsiao NY; Castillo-Mancilla J; Lesosky M; Myer L
    Clin Infect Dis; 2022 Sep; 75(5):761-767. PubMed ID: 34979553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring.
    Niu X; Kubiak RW; Siriprakaisil O; Klinbuyaem V; Sukrakanchana PO; Cressey R; Okochi H; Gandhi M; Cressey TR; Drain PK
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac405. PubMed ID: 36004315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons With HIV Receiving Tenofovir Alafenamide and Emtricitabine-Based Antiretroviral Therapy (QUANTI-TAF).
    Coyle RP; Morrow M; Mann SC; Mainella V; Ellis SL; Schwab S; Coppinger C; Barker N; Ellison L; Zheng JH; Al Zuabi S; Alpert PE; Carnes TC; Buffkin DE; Chai PR; Bushman LR; Kiser JJ; MaWhinney S; Brooks KM; Anderson PL; Castillo-Mancilla JR
    Clin Infect Dis; 2024 Nov; 79(5):1233-1241. PubMed ID: 38636950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.
    Singh Y; Castillo-Mancilla J; Madimabe R; Jennings L; Ferraris CM; Robbins RN; Anderson PL; Remien RH; Orrell C
    AIDS Res Ther; 2023 Sep; 20(1):67. PubMed ID: 37705102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.
    Havens PL; Tamhane A; Stephensen CB; Schuster GU; Gordon CM; Liu N; Wilson CM; Hosek SG; Anderson PL; Kapogiannis BG; Mulligan K
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):123-128. PubMed ID: 30280906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women.
    Phillips TK; Sinxadi P; Abrams EJ; Zerbe A; Orrell C; Hu NC; Brittain K; Gomba Y; Norman J; Wiesner L; Myer L; Maartens G
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):311-318. PubMed ID: 30893125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men.
    van den Elshout MA; Hoornenborg E; Coyer L; Anderson PL; Davidovich U; de Vries HJ; Prins M; Schim van der Loeff MF;
    Sex Transm Infect; 2023 Aug; 99(5):303-310. PubMed ID: 37258273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIV.
    Hirsh ML; Edwards JA; Robichaux C; Brijkumar J; Moosa MS; Ofotokun I; Johnson BA; Pillay S; Pillay M; Moodley P; Sun YV; Liu C; Dudgeon MR; Ordoñez C; Kuritzkes DR; Sunpath H; Morrow M; Anderson PL; Ellison L; Bushman LR; Marconi VC; Castillo-Mancilla JR
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad360. PubMed ID: 37469618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa.
    Jennings L; Robbins RN; Nguyen N; Ferraris C; Leu CS; Dolezal C; Hsiao NY; Mgbako O; Joska J; Castillo-Mancilla JR; Myer L; Anderson PL; Remien RH; Orrell C;
    AIDS; 2022 Jun; 36(7):933-940. PubMed ID: 35131960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative tenofovir diphosphate exposure in persons with HIV taking single- vs. multiple-tablet regimens.
    Coyle RP; Morrow M; MaWhinney S; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
    Pharmacotherapy; 2022 Aug; 42(8):641-650. PubMed ID: 35707973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women.
    Castillo-Mancilla JR; Searls K; Caraway P; Zheng JH; Gardner EM; Predhomme J; Bushman LR; Anderson PL; Meditz AL
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):428-32. PubMed ID: 25328112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV.
    Morrow M; MaWhinney S; Coyle RP; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
    J Infect Dis; 2019 Jul; 220(4):635-642. PubMed ID: 30942881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Income Inequality Is Associated With Low Cumulative Antiretroviral Adherence in Persons With Human Immunodeficiency Virus.
    Vernon F; Morrow M; MaWhinney S; Coyle R; Coleman S; Ellison L; Zheng JH; Bushman L; Kiser JJ; Galárraga O; Anderson PL; Castillo-Mancilla J
    Open Forum Infect Dis; 2020 Oct; 7(10):ofaa391. PubMed ID: 33072812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.
    Castillo-Mancilla JR; Zheng JH; Rower JE; Meditz A; Gardner EM; Predhomme J; Fernandez C; Langness J; Kiser JJ; Bushman LR; Anderson PL
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):384-90. PubMed ID: 22935078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
    Yager J; Castillo-Mancilla J; Ibrahim ME; Brooks KM; McHugh C; Morrow M; McCallister S; Bushman LR; MaWhinney S; Kiser JJ; Anderson PL
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):323-330. PubMed ID: 32539288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.